TTM
$7.09M
YoY change
+1128.3%
5Y CAGR
-11.2%
Peak year (2021)
$208.38M
Cumulative gross profit
$230.09M
Gross Profit history chart for Ovid Therapeutics (OVID) from 2014 to 2025
Latest: $6.95M
Gross Profit growth chart for Ovid Therapeutics (OVID) from 2014 to 2025
Latest: +1128.3%
Gross Profit history table for Ovid Therapeutics (OVID) from 2014 to 2025
| 2025 | $6.95M | +1128.3% | +$6.39M | ||
| 2024 | $566.00K | +44.4% | +$174.00K | ||
| 2023 | $392.00K | -73.9% | −$1.11M | ||
| 2022 | $1.50M | -99.3% | −$206.88M | ||
| 2021 | $208.38M | +1551.6% | +$195.77M | ||
| 2020 | $12.62M | — | +$12.62M | ||
| 2019 | $0.00 | -100.0% | +$142.00K | ||
| 2018 | −$142.00K | +76.8% | −$61.69K | ||
| 2017 | −$80.31K | +42.1% | −$23.80K | ||
| 2016 | −$56.51K | +379.8% | −$44.73K | ||
| 2015 | −$11.78K | — | −$11.78K | ||
| 2014 | $0.00 | — | — |
- 2025$6.95M+1128.3%
- 2024$566.00K+44.4%
- 2023$392.00K-73.9%
- 2022$1.50M-99.3%
- 2021$208.38M+1551.6%
- 2020$12.62M—
- 2019$0.00-100.0%
- 2018−$142.00K+76.8%
- 2017−$80.31K+42.1%
- 2016−$56.51K+379.8%
- 2015−$11.78K—
- 2014$0.00—
Gross Profit values are taken from Ovid Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Ovid Therapeutics (OVID)
According to Ovid Therapeutics's latest reported financial statements, the company's current gross profit (TTM) is $7.09M. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Ovid Therapeutics (OVID) gross profit totalled $6.95M – surged 1128.3% year-over-year.
Ovid Therapeutics gross profit has grown for 2 consecutive years, with a -11.2% compound annual growth rate over 2020–2025 (5 years).
Ovid Therapeutics gross profit plunged from $208.38M in 2021 to $6.95M in 2025, a 96.7% drawdown.
$208.38M stands as the all-time-high annual gross profit, posted in 2021, against a low of −$142.00K during 2018.
Ovid Therapeutics Gross Profit by Year
Ovid Therapeutics Gross Profit 2025: $6.95M
In 2025, Ovid Therapeutics reported gross profit of $6.95M, surged 1128.3% from 2024.
Ovid Therapeutics Gross Profit 2024: $566.00K
Ovid Therapeutics gross profit in 2024 was $566.00K, surged 44.4% from 2023.
Ovid Therapeutics Gross Profit 2023: $392.00K
2023's gross profit for Ovid Therapeutics came in at $392.00K, plunged 73.9% below 2022.
Ovid Therapeutics Gross Profit 2022: $1.50M
Ovid Therapeutics posted gross profit of $1.50M in 2022, plunged 99.3% below 2021.
Ovid Therapeutics Gross Profit 2021: $208.38M
Ovid Therapeutics gross profit in 2021 was $208.38M.
See more financial history for Ovid Therapeutics (OVID).
Sector peers by Gross Profit
Healthcare peers of Ovid Therapeutics (OVID), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation